LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

LLY

758.12

+2.89%↑

JNJ

151.16

+1.45%↑

UNH

291.21

+7.79%↑

ABBV

182.59

+1.45%↑

NVO

64.13

-2.91%↓

Search

CVS Health Corp.

Atvērts

SektorsVeselības aprūpe

62.42 3.52

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

60.39

Max

62.67

Galvenie mērījumi

By Trading Economics

Ienākumi

156M

1.8B

Pārdošana

-3.1B

95B

P/E

Sektora vidējais

15.468

56.602

EPS

2.25

Dividenžu ienesīgums

3.97

Peļņas marža

1.881

Darbinieki

219,000

EBITDA

525M

4.6B

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+31.19% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

3.97%

2.45%

Nākamie ieņēmumi

2025. g. 6. aug.

Nākamais dividenžu datums

2025. g. 31. jūl.

Nākamais Ex dividenžu datums

2025. g. 21. jūl.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-1.3B

82B

Iepriekšējā atvēršanas cena

58.9

Iepriekšējā slēgšanas cena

62.42

Ziņu noskaņojums

By Acuity

28%

72%

69 / 382 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

CVS Health Corp. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 13. maijs 17:18 UTC

Galvenie tirgus virzītāji

Health Insurers See Shares Drop After UnitedHealth Suspends Guidance

2025. g. 1. maijs 20:13 UTC

Galvenie tirgus virzītāji

Shares Fall for Some Insurance Companies, Brokers Named in DOJ Complaint

2025. g. 1. maijs 13:35 UTC

Peļņas
Galvenie tirgus virzītāji

CVS Stock Climbs After Wegovy Deal, Strong 1Q

2025. g. 1. maijs 12:43 UTC

Galvenie tirgus virzītāji

Novo Nordisk Shares Jump After Wegovy Deal With CVS

2025. g. 14. maijs 09:30 UTC

Top Ziņas

Why UnitedHealth's Blowup May Be More Isolated Than Investors Think -- Heard on the Street -- WSJ

2025. g. 12. maijs 16:58 UTC

Tirgus saruna

Trump's Drug-Price Order May Have Little Impact on Drugmakers -- Market Talk

2025. g. 4. maijs 04:05 UTC

Iegādes, apvienošanās, pārņemšana

UnitedHealth's Stock Is Ailing. A Bigger Business Hasn't Helped. -- Barrons.com

2025. g. 2. maijs 11:15 UTC

Peļņas

The Market Rally Is Strong, This Would Send It -2-

2025. g. 2. maijs 11:15 UTC

Peļņas

The Market Rally Is Strong, This Would Send It Stratospheric. And 5 Other Things to Know Today. -- Barrons.com

2025. g. 1. maijs 23:14 UTC

Top Ziņas

Justice Department Sues Big Medicare Insurers Alleging Kickbacks -- 2nd Update

2025. g. 1. maijs 21:20 UTC

Top Ziņas

Justice Department Sues Big Medicare Insurers Alleging Kickbacks -- Update

2025. g. 1. maijs 21:07 UTC

Tirgus saruna

Weight-Loss Drug Competitive Pressures Hammer Eli Lilly Shares -- Market Talk

2025. g. 1. maijs 16:30 UTC

Peļņas

CVS Stock Surges on Blowout Earnings, Guidance Hike -- Barrons.com

2025. g. 1. maijs 14:41 UTC

Peļņas

CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business -- Update

2025. g. 1. maijs 14:07 UTC

Peļņas

Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling. -- Barrons.com

2025. g. 1. maijs 13:30 UTC

Peļņas

CVS Stock Surges on Blowout Earnings, Guidance Hike -- Barrons.com

2025. g. 1. maijs 11:58 UTC

Peļņas

Eli Lilly Earnings Beat Expectations. Why the Stock Is Falling. -- Barrons.com

2025. g. 1. maijs 10:44 UTC

Peļņas

CVS Health Beats Earnings Expectations, Hikes Guidance. The Stock Is Surging. -- Barrons.com

2025. g. 1. maijs 10:41 UTC

Peļņas

CVS Health's Stock Surges Toward A One-Year High After An Earnings Triple Play -- MarketWatch

2025. g. 1. maijs 10:31 UTC

Peļņas

CVS Health Earnings Beat Expectations. The Stock Is Surging. -- Barrons.com

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health 1Q Rev $94.59B >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health 1Q Same-Store Sales Up 14.2% >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health 1Q Net $1.78B >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health 1Q Healthcare Benefits Segment Revenue $34.81B >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health 1Q Pharmacy & Consumer Wellness Segment Revenue Up 11.1% >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health 1Q Pharmacy & Consumer Wellness Segment Revenue $31.91B >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health 1Q Pharmacy Same-Store Sales Up 17.7% >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health Sees FY EPS $4.23-EPS $4.43 >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health 1Q Healthcare Benefits Segment Revenue Up 8.0% >CVS

2025. g. 1. maijs 10:30 UTC

Peļņas

CVS Health Sees FY Adj EPS $6.00-Adj EPS $6.20 >CVS

Salīdzinājums

Cenas izmaiņa

CVS Health Corp. Prognoze

Cenas mērķis

By TipRanks

31.19% augšup

Prognoze 12 mēnešiem

Vidējais 79.33 USD  31.19%

Augstākais 95 USD

Zemākais 71 USD

Pamatojoties uz 19 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi CVS Health Corp. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

19 ratings

16

Pirkt

3

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

65.92 / 68.28Atbalsts un pretestība

Īstermiņā

Very Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

Weak Bullish Evidence

Noskaņojums

By Acuity

69 / 382 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par CVS Health Corp.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.